Novartis fights India for cancer pill patent

August 31, 2012
Ankur Sohanpal

Novartis will be going to the Supreme Court in India to seek protection in form of patent for its cancer drug Glivec. Read more here. According to health campaigners in India, if Novartis is to win the case, it would mean handing down a ‘death sentence’ to the poor and ill in the developing world (read here). Read more here.



View Our Publications

Case Studies, Learnings and More!

View Publications


Footer Image

Get In Touch